Former head of investments at Alibaba Group's India business Raghav Bahl and 9Unicorns ex-partner Soham Avlani on Thursday announced the launch of PROMAFT Partners -- a Rs 1,000-crore venture capital fund. The sector-agnostic fund seeks to invest in companies that have proven exceptional 'product-market-fit'. It plans to make 10-12 investments, with two-three investments in a year. "Growing without product-market-fit is like driving fast in the wrong direction. And product-market-fit without sustainable competitive advantage doesn't create shareholder value. We encourage our entrepreneurs to grow slowly, while investing in the core fundamentals of the business. "We plan to make two-three investments per year. We are backed by prudent investors, which gives our entrepreneurs the advantage to build for the long term," Bahl said. The fund is also backed by Indian family offices and market leaders like Paytm, Zomato, Browserstack, Livspace, PharmEasy, and VideoVerse who will also ...
Collectively, the hub targets to mobilise $100 million in the Indian deeptech ecosystem
An analysis of 10 sectors that received the most funding in 2023 shows that nine of them experienced an increase in the time taken to reach Series A compared to 2019
Some are expecting the M&A market for AI startups to pick up in the second half, as tech companies with capital or sought-after stock, from Nvidia to Databricks, have been acquisitive
Venture Capital firm Peak XV is the most active investor in Indian startups with investment in 47 entities, according to ASK Private Wealth Hurun India Future Unicorn Index 2024. According to the index report, Peak XV is followed by Accel which has invested in 25 companies that are poised to become the next generation of unicorns. "With an impressive portfolio of 47 investments, Peak XV Partners emerges as the top investor in the ASK Private Wealth Hurun India Future Unicorn Index 2024, the report said, adding that Peak XV Partners registered successes by investing in Turtlemint, CleverTap and Classplus, among others. The report said that the number of unicorns -- startups valued at over USD 1 billion -- slipped by one to 67 in 2023. Peak XV is an investor in 70 per cent of India's unicorns. "Ranking 2nd on the ASK Private Wealth Hurun India Future Unicorn Index 2024, Accel has made investments in 25 companies that are poised to become the next generation of unicorns. Their portfo
The firm made investments in 47 potential unicorns such as Turtlemint, CleverTap, and Classplus.
There were 465 deals this year, compared to 758 reported in the same period last year
Mathias said there is a correction taking place in the ecosystem compared to three years ago when companies were given money unjustifiably
The number of deals in April stood at 98, which was 56 per cent higher than the year-ago period, the report by EY, a consultancy firm, and industry lobby grouping IVCA said
No deal can advance without mutual trust. Enhancing trust is achievable by implementing higher governance standards, clear communication, ethical practices
The Indian private equity and venture capital investments declined by about 35 per cent to around USD 39 billion in 2023 from USD 62 billion in 2022, according to a joint report by Bain & Company and IVCA released on Thursday. The private equity (PE) investments in India dropped by 18 per cent to USD 29.6 billion from a peak value of USD 36 billion in 2022. The drop in VC investments was much sharper, with total investments at USD 9.6 billion in 2023 versus USD 25.7 billion in 2022. "Mirroring the global trend, Indian private equity and venture capital (PE-VC) investment softened by about 35 per cent from approximately USD 62 billion in 2022 to around USD 39 billion in 2023, returning to pre-Covid-19 activity levels," the report said. The report saw 2023 as a marquee year for Indian exits with exit values soaring by 15 per cent to USD 29 billion with sale of shares in 340 entities. "In a year marked by global economic uncertainties, India's private equity landscape demonstrated ..
75% of PE-VC investments were directed towards conventional sectors such as healthcare, retail, energy, advanced manufacturing
This third fund has garnered strong support from a diverse mix of investors, including insurance companies, family offices, corporate treasuries, and high-net-worth individuals (HNIs)
Fund will invest in 'high-growth companies with strong potential', says venture capital firm
Venture Capital firm IvyCap Ventures has raised Rs 2,100 crore through its Fund III, with 90 per cent of the corpus coming from domestic investors. Fund III had a basic corpus of Rs 1,500 crore and a provision to raise an additional Rs 600 crore as greenshoe option. "We have raised Rs 2,100 crore. Majority of the fund has come from our existing investors and 90 per cent is domestic capital," IvyCap Ventures Founder and Managing Partner Vikram Gupta told PTI. "Despite challenges in domestic capital flow, we have stuck to our theory that there is enough domestic capital which will continue to grow. With Fund III we have proved it," he said. The Fund III is almost 4 times the size of Fund II, IvyCap said, adding that it plans to invest in Indian startups over a period of 12 years. The Fund plans to invest in about 25 companies at Series A with an average starting investment amount of Rs 30-50 crore. "We are sector agnostic fund. We have already committed around 40 per cent of the fu
Capria and other investors in Awign, India's largest tech-led, on-demand work fulfilment platform, have sold their stake in the company in a buyout by Japanese conglomerate Mynavi Corporation
In India, the company has 27 active investments including in Swiggy, NSE India, Duroflex, Finova Capital, Kishlay Foods, Mintifi, Quikr among others
Investment dips as sector grapples with new rules and market dynamics
Venture capital fund Tomorrow Capital on Tuesday said it has led a USD 2.7 million (over Rs 20 crore) fundraise for VitusCare, a kidney care startup based in Gurugram. In addition to Tomorrow Capital's contribution, the Series A funding round saw participation from existing investor 1Crowd, alongside support from 3i Partners and a consortium of angel investors, totalling approximately USD 5 million in funding across all the funding rounds, the company said in a statement. The fresh capital injection will empower VitusCare to aggressively expand its operations, with a targeted focus on deeper penetration into 'Bharat', it added. "As the prevalence of lifestyle-related disorders such as diabetes and hypertension continue to rise, the demand for kidney-related services is poised to increase exponentially. VitusCare's innovative approach and impressive growth trajectory align perfectly with our mission to invest in solutions that make a meaningful impact on public health," Tomorrow ...
VC investment in crypto startups reached $2.5 billion during the first quarter of 2024, a 32% increase from the last quarter and roughly even with the same period last year